MDNC Share Price Performance
US$5.00
0.00 (0.00%)
Price US$5.00
Share PriceUS$5.00
MDNC Community Narratives
There are no narratives available yet.
Recent MDNC News & Updates
No updates
Medinotec Inc. Key Details
Last Reported Earnings
Feb 28, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.18
- Gross Margin
- 53.34%
- Net Profit Margin
- 23.70%
- Debt/Equity Ratio
- 22.0%
Medinotec Inc. Competitors
About MDNC
- Founded
- 2021
- Employees
- 37
- CEO
- WebsiteView website
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.
South African Market Performance
- 7 Days: 0.2%
- 3 Months: 9.1%
- 1 Year: 21.5%
- Year to Date: 14.6%
Over the last 7 days, the market has remained flat, although notably the Materials sector gained 4.3% in that time. Meanwhile, the market is actually up 22% over the past year. As for the next few years, earnings are expected to grow by 19% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading